Landos Biopharma, Inc. (LABP) Social Stream
LANDOS BIOPHARMA INC (LABP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LABP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-20 | 6 | $50 | $15 | $32.833 | $3.85 | 752.81% |
| 2021-11-16 | 6 | $50 | $15 | $30 | $3.85 | 679.22% |
| 2022-01-03 | 6 | $50 | $7 | $28.666 | $3.85 | 644.57% |
| 2022-03-24 | 5 | $50 | $7 | $26.166 | $3.85 | 579.64% |
| 2022-04-12 | 6 | $50 | $1.4 | $21.4 | $3.85 | 455.84% |
| 2022-05-12 | 6 | $50 | $0.8 | $24.16 | $3.85 | 527.53% |
| 2022-05-13 | 6 | $50 | $0.8 | $18.2 | $3.85 | 372.73% |
| 2022-08-12 | 5 | $50 | $0.8 | $17.933 | $3.85 | 365.79% |
| 2022-11-11 | 3 | $2 | $0.2 | $1.1 | $3.85 | -71.43% |
| 2023-02-08 | 3 | $2 | $0.1 | $1.05 | $3.85 | -72.73% |
| 2023-03-24 | 2 | $2 | $0.1 | $1.05 | $3.85 | -72.73% |
| 2023-05-12 | 1 | $10 | $10 | $10 | $3.85 | 159.74% |
| 2023-05-16 | 2 | $1 | $0.1 | $0.55 | $3.85 | -85.71% |
| 2023-08-10 | 1 | $5 | $5 | $5 | $3.85 | 29.87% |
Price Target Last Issued August 10, 2023
The Trend in the Analyst Price Target
LABP's average price target has moved down $23.33 over the prior 25 months.
Over the past 39 weeks, LABP's average upside potential has been 693.45%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 3 | 2 | 0.1 | 1.05 | 0.385 | 172.73% |
| 2023-05-12 | 2 | 10 | 10.0 | 10.00 | 0.298 | 3255.7% |
| 2023-05-12 | 1 | 10 | 10.0 | 10.00 | 0.298 | 3255.7% |
| 2023-05-16 | 2 | 1 | 0.1 | 0.55 | 0.290 | 89.66% |
| 2023-05-16 | 2 | 1 | 0.1 | 0.55 | 2.905 | -81.07% |
LABP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
LABP's average broker recommendation rating worsened by 0.5 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- LANDOS BIOPHARMA INC's variance in analysts' estimates is lower than -1919.05% of all US stocks.
- In the context of all US stocks, LANDOS BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 1399.13% of them.
- LABP has a greater number of analysts covering the stock than 504.94% of Healthcare stocks.
- LABP has a greater average analyst price target than 885.87% of stocks in the small market cap category.
In the Pharmaceutical Products industry, SNSE, PHVS, and CNTB are the three stocks most similar to LANDOS BIOPHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is LABP a Buy, Hold or Sell? See the POWR Ratings now!